A randomized controlled trial of levosimendan to reduce mortality in high risk cardiac surgery patients (CHEETAH): rationale and design by Zangrillo, A, Alvaro, G., MD, Pisano, A., MD, Guarracino, F., MD, Lobreglio, R., MD, Bradic, N., MD, Lembo, R., MSc, Gianni, S., MD, Calabrò, M.G., MD, Likhvantsev, V., PhD, Grigoryev, E., MD, Buscaglia, G., MD, Pala, G., MD, Auci, E., MD, Amantea, B., MD, Monaco, F., MD, De Vuono, G., MD, Corcione, A., MD, Galdieri, N., MD, Cariello, C., MD, Bove, T., MD, Fominskiy, E., MD, PhD, Auriemma, S., MD, Baiocchi, M., MD, Bianchi, A., MD, Frontini, M., MD, Paternoster, G., MD, Sangalli, F., MD, Wang, C.Y., MBChB, Zucchetti, M.C., MD, Biondi Zoccai, G., MD, MSc, Gemma, M., MD, Lipinski, M.J., MD, PhD, Lomivorotov, V.V., MD, PhD, Landoni, G

Get full text